| Dr Gregory P Sachs, MD | |
|
1215 Duff Avenue, Ames, IA 50010-3014 | |
| (515) 239-4725 | |
| (515) 956-4130 |
| Full Name | Dr Gregory P Sachs |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 17 Years |
| Location | 1215 Duff Avenue, Ames, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942406038 | NPI | - | NPPES |
| 003719165 | Other | MEDICARE | |
| 200879320A | Medicaid | KS | |
| 200879320C | Other | KS | KS MEDICAID, ST TERESA LOCATION |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 38823 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mary Greeley Medical Center | Ames, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mcfarland Clinic Pc | 1254244239 | 320 |
News Archive
Imagine a sensor implanted in your body that signals when you're getting sick - almost like the "check engine" light in a car. That scenario sounds like pure fantasy, but it may be closer to reality than many people think, according to an article in the current edition of Chemical & Engineering News, ACS' weekly newsmagazine.
A drug originally developed to stop cancerous tumors may hold the potential to prevent abnormal brain cell growth and learning disabilities in some children, if they can be diagnosed early enough, a new animal study suggests.
Scientists are reporting development and successful testing of a rapid and accurate test to tell the difference between bacterial and viral infections. Those common afflictions often have similar symptoms but vastly different treatments - antibiotics work for bacterial infections but not for viruses. The report appears in ACS' journal Analytical Chemistry.
Shire plc, the global specialty biopharmaceutical company, today announced topline results from FAST-3 (For Angioedema Subcutaneous Treatment), the largest of the Phase III trials studying the use of Firazyr (icatibant) for treatment of acute attacks of hereditary angioedema (HAE).
› Verified 1 days ago
| Entity Name | Mcfarland Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639135643 PECOS PAC ID: 1254244239 Enrollment ID: O20031106000338 |
News Archive
Imagine a sensor implanted in your body that signals when you're getting sick - almost like the "check engine" light in a car. That scenario sounds like pure fantasy, but it may be closer to reality than many people think, according to an article in the current edition of Chemical & Engineering News, ACS' weekly newsmagazine.
A drug originally developed to stop cancerous tumors may hold the potential to prevent abnormal brain cell growth and learning disabilities in some children, if they can be diagnosed early enough, a new animal study suggests.
Scientists are reporting development and successful testing of a rapid and accurate test to tell the difference between bacterial and viral infections. Those common afflictions often have similar symptoms but vastly different treatments - antibiotics work for bacterial infections but not for viruses. The report appears in ACS' journal Analytical Chemistry.
Shire plc, the global specialty biopharmaceutical company, today announced topline results from FAST-3 (For Angioedema Subcutaneous Treatment), the largest of the Phase III trials studying the use of Firazyr (icatibant) for treatment of acute attacks of hereditary angioedema (HAE).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gregory P Sachs, MD 1215 Duff Avenue, Ames, IA 50010-3014 Ph: (515) 239-4725 | Dr Gregory P Sachs, MD 1215 Duff Avenue, Ames, IA 50010-3014 Ph: (515) 239-4725 |
News Archive
Imagine a sensor implanted in your body that signals when you're getting sick - almost like the "check engine" light in a car. That scenario sounds like pure fantasy, but it may be closer to reality than many people think, according to an article in the current edition of Chemical & Engineering News, ACS' weekly newsmagazine.
A drug originally developed to stop cancerous tumors may hold the potential to prevent abnormal brain cell growth and learning disabilities in some children, if they can be diagnosed early enough, a new animal study suggests.
Scientists are reporting development and successful testing of a rapid and accurate test to tell the difference between bacterial and viral infections. Those common afflictions often have similar symptoms but vastly different treatments - antibiotics work for bacterial infections but not for viruses. The report appears in ACS' journal Analytical Chemistry.
Shire plc, the global specialty biopharmaceutical company, today announced topline results from FAST-3 (For Angioedema Subcutaneous Treatment), the largest of the Phase III trials studying the use of Firazyr (icatibant) for treatment of acute attacks of hereditary angioedema (HAE).
› Verified 1 days ago
Benjamin P Schlicher, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1215 Duff Avenue, Ames, IA 50010 Phone: 515-239-4725 Fax: 515-956-4130 | |
Justin W Davis, MD Surgery Medicare: Medicare Enrolled Practice Location: 1215 Duff Ave, Ames, IA 50010 Phone: 515-239-4427 | |
Dr. Bruce M. Hardy, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 1215 Duff Ave, Ames, IA 50010 Phone: 515-239-4725 | |
Dr. Mark Taylor, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1215 Duff Ave, Ames, IA 50010 Phone: 515-239-4725 Fax: 515-956-4130 | |
Dr. Mark Thomas Vandenberg, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1215 Duff Ave, Ames, IA 50010 Phone: 515-239-4725 Fax: 515-956-4130 | |
Alexander Wickenkamp, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1215 Duff Ave, Ames, IA 50010 Phone: 515-239-4427 |